Elevation Wealth Partners’s Altimmune ALT Stock Holding History

Elevation Wealth Partners’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870	Hold	286	–	–	﹤0.01%	1266
2026 Q1	$881	Hold	286	–	–	﹤0.01%	1004
2025 Q4	$1.03K	Hold	286	–	–	﹤0.01%	862
2025 Q3	$1.08K	Hold	286	–	–	﹤0.01%	743
2025 Q2	$1.11K	Hold	286	–	–	﹤0.01%	439
2025 Q1	$1.43K	Buy	286 +41	+17%	+$260	﹤0.01%	437
2024 Q4	$1.77K	Buy	245 +45	+23%	+$344	﹤0.01%	440
2024 Q3	$1.23K	Buy	+200	New	+$1.35K	﹤0.01%	430

Other funds holding ALT

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BWCS

Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

BWM

Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SFWA

Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Elevation Wealth Partners's ALT Position: Q2 2026 in Review

Elevation Wealth Partners held its Altimmune (ALT) position steady in Q2 2026 at 286 shares worth $870. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Elevation Wealth Partners first reported a position in ALT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.77K in Q4 2024. 36 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Elevation Wealth Partners held 286 shares of Altimmune worth $870 as of Q2 2026.
Elevation Wealth Partners left its Altimmune share count unchanged in Q2 2026.
Altimmune made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1266 holding.
Elevation Wealth Partners first reported a position in Altimmune in Q3 2024 and has held it in 8 quarters since.
Elevation Wealth Partners's Altimmune position peaked at $1.77K in Q4 2024.
36 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.